FY26 1-31JAN 2026 -- mat (90F) medications only - mckesson contract acct #077960 and 677508-- 90F/ 1060ADB funding for mat medication purchase (controlled & non-controlled medications) requesting…
Ended Awarded Last action
- Contract number
- 15B10926F00000050
- Awardee
-
Mckesson Corporation UEI S1RUKWWRYFL6
- Awarding agency
-
Federal Medical Center Lexington
Correctional Facilities, Department of Justice
- Obligated
- $19,724
Award facts
- Contract value 100% obligated
- $19,724.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Irving, TX 75039, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,706 | |
| Original award | $22,430 |
About this award
McKesson Corporation, a major pharmaceutical distribution company headquartered in Irving, Texas, received a delivery order from the Federal Medical Center Lexington (a civilian facility under the Bureau of Prisons) on January 1, 2026, for Medication-Assisted Treatment (MAT) medications. The contract, valued at $19,724.32 with a ceiling of $22,430.17, covers both controlled and non-controlled pharmaceutical purchases through McKesson's existing contract accounts #077960 and #677508. Performance will be completed by January 31, 2026, with delivery to Irving, Texas. This award utilizes a firm fixed-price contract type with no small business set-aside designation, consistent with McKesson's established competitive standing as a large business contractor.
This delivery order reflects the continuation of McKesson's substantial role as a critical pharmaceutical supplier to the federal correctional healthcare system. The Federal Bureau of Prisons relies on McKesson to provide essential medications supporting various correctional facilities nationwide, and MAT medications are particularly important therapeutic agents for incarcerated individuals with opioid use disorders. The award is issued under McKesson's existing federal contract vehicle supporting pharmaceutical procurement across multiple Bureau of Prisons facilities, part of the company's broader federal healthcare engagement that extends to the Indian Health Service, Department of Homeland Security, and other federal agencies.
Description
FY26 1-31JAN 2026 -- mat (90F) medications only - mckesson contract acct #077960 and 677508-- 90F/ 1060ADB funding for mat medication purchase (controlled & non-controlled medications) requesting $22,430.17
Quick answers
Who was awarded contract 15B10926F00000050?
15B10926F00000050 was awarded to Mckesson Corporation by Federal Medical Center Lexington (Correctional Facilities) on January 1, 2026.
How much is contract 15B10926F00000050 worth?
The government has obligated $19,724 on 15B10926F00000050.
Is contract 15B10926F00000050 an order under another contract?
Yes. 15B10926F00000050 is a delivery order under 36W79720D0001, an indefinite delivery contract.
Was contract 15B10926F00000050 competed?
The extent of competition for 15B10926F00000050 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award